Lineage Cell Therapeutics (LCTX) Cash & Current Investments (2010 - 2026)
Lineage Cell Therapeutics (LCTX) recorded Cash & Current Investments of $50.83 million in Q2 2026, up 20.2% from $42.29 million a year earlier but down 4.8% from the prior quarter.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Cash & Current Investments (2010 - 2026) Analysis & Trends
At the end of FY2025, Lineage Cell Therapeutics reported Cash & Current Investments of $55.78 million, up 16.7% from FY2024.
- Annual Cash & Current Investments has a five-year compound annual growth rate of 6.1% (FY2020 to FY2025).
- Across earlier years, Cash & Current Investments came in at $47.81 million in FY2024 (+34.7%), $35.49 million in FY2023 (-38.7%), $57.88 million in FY2022 (-0.8%) and $58.36 million in FY2021 (+40.4%).
- Quarterly Cash & Current Investments has ranged from $32.71 million in Q3 2024 to $79.94 million in Q1 2022 over the past five years.
- On a year-over-year basis, Cash & Current Investments has increased for seven consecutive quarters, with growth averaging 13.2% over the last eight quarters.
- Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 71.1% in Q3 2021, against a decline of 41.4% in Q1 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $53.38 million (Q1 2026), $55.78 million (Q4 2025) and $40.49 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Lineage Cell Therapeutics | 235.20 Mn | 33.61 Mn | - | 50.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 50.83 Mn |
| Mar 31, 2026 | 53.38 Mn |
| Dec 31, 2025 | 55.78 Mn |
| Sep 30, 2025 | 40.49 Mn |
| Jun 30, 2025 | 42.29 Mn |
| Mar 31, 2025 | 47.91 Mn |
| Dec 31, 2024 | 47.81 Mn |
| Sep 30, 2024 | 32.71 Mn |
| Jun 30, 2024 | 38.50 Mn |
| Mar 31, 2024 | 43.62 Mn |
| Dec 31, 2023 | 35.49 Mn |
| Sep 30, 2023 | 41.37 Mn |
| Jun 30, 2023 | 45.93 Mn |
| Mar 31, 2023 | 46.81 Mn |
| Dec 31, 2022 | 57.88 Mn |
| Sep 30, 2022 | 66.36 Mn |
| Jun 30, 2022 | 72.03 Mn |
| Mar 31, 2022 | 79.94 Mn |
| Dec 31, 2021 | 58.36 Mn |
| Sep 30, 2021 | 65.10 Mn |
API Access
Lineage Cell Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=LCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();